Chronic Stress Induces Shrinkage of Medial Amygdala Neurons in Mice: Recovery by the Fast-Acting Candidate Antidepressant Acetyl-L-Carnitine
A recent study in Molecular Psychiatry provides new evidence that chronic stress generates structural remodelling of the brain amygdala, and particularly the shrinkage of medial amygdala neurons in mice.
Chronic stress has been linked to cognitive impairment, but it is also known that stress modifies the neuronal architecture in several brain cognitive areas.
However, little is known about the effects of chronic stressful conditions, and the use of antidepressants regarding the neuronal remodelling in the amygdala. This brain structure is involved with stress reactivity, memory, emotional reactions and fear, and anxiety-related behavioral responses.
Chronic stress modifies structurally our brain cells architecture, as part of an adaptive strategy, but failed resilience has been linked to the onset and recurrence of major depression. Such structural plasticity and neuronal remodelling are well-known to occur in areas involved with memory and cognition, such as the hippocampal area and the prefrontal cortex.
However, only recently, the amygdala has been linked to this process, when neurons in the basolateral amygdala were shown to exhibit enhanced dendritic arborisation in response to chronic immobilization stress (CIS).
Now, in the Molecular Psychiatry study, T Lau and colleagues, from the Laboratory of Neuroendocrinology of the Rockefeller University, NY, USA, showed that chronically stressed mice exhibit structural modifications in neurons of the amygdala that can be partially prevented by treating the animals with the novel antidepressant candidate acetyl-L-carnitine (LAC).
The authors used the chronic restraint stress (CRS) paradigm, by restraining the animals for 21 consecutive days, and observed different effects of stress over different nuclei of the amygdala.
They found that in the basolateral amygdala (mainly involved with external information processing) stress was associated with an increase in dendritic length and number of intersections in pyramidal neurons (a sign of plasticity and adaptation).
In apparent contrast, the neuronal branches of the medial amygdala (mainly involved with the expression of emotions) appeared to shrink after 21 days of CRS. Of note, the CRS effects in the medial amygdala were specific to the stellate neurons that showed the dendritic shrinkage.
Lau and colleagues then treated the mice orally with LAC, known for its almost immediate anti-depressive effect. Additionally to the cognitive and social anti-depressive effect observed in the treated mice, oral LAC increased neuronal branching, where medial amygdala stellate neurons were more complex and longer. No differences were observed in other types of neurons in these brain nuclei.
The authors discuss that the stress-induced structural shrinkage in the medial amygdala, as reported in this study, may represent a homeostatic adaptation to the increased glutamatergic overflow from the adjacent hippocampus, which directly projects to the medial amygdala.
The authors also discuss that stellate neurons from the medial amygdala are important components involved with the neuronal, and subsequent behavioral responses to chronic stress.
They conclude that the medial amygdala is identified in this study as a novel target of structural and functional remodeling by stressors and the new antidepressant candidate acetyl-L-carnitine.
Source: Mol Psychiatry 2016 May 31 doi: 10.1038/mp.2016.68. [Epub ahead of print]
Read More: Molecular Psychiatry
Disclaimer: The information contained herein is NOT intended and should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider, OR instructional for medical diagnosis or treatment; see more details